Stay updated on Pembrolizumab in mCRPC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in mCRPC Clinical Trial page.

Latest updates to the Pembrolizumab in mCRPC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedSite software version updated from v3.5.0 to v3.5.2. No user-facing changes to study content or page structure are evident.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check42 days agoChange DetectedAdded a new frontend revision label: Revision: v3.5.0, and removed the previous Revision: v3.4.3.SummaryDifference0.1%

- Check49 days agoChange DetectedRevision label in the site footer updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page shows a site revision: 'Revision: v3.4.2' is listed, with a prior entry for v3.4.1 and a legacy government funding notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check85 days agoChange DetectedAdded a site-wide funding notice and updated the page to revision v3.4.1, removing v3.4.0.SummaryDifference0.4%

- Check92 days agoChange DetectedAdded a glossary toggle and a 'Last Update Submitted that Met QC Criteria' label; capitalization adjusted for 'No FEAR Act Data' and the site revision updated to v3.4.0.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in mCRPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in mCRPC Clinical Trial page.